The French National Registry of patients with Facioscapulohumeral muscular dystrophy
Abstract Background Facioscapulohumeral muscular dystrophy is a rare inherited neuromuscular disease with an estimated prevalence of 1/20,000 and France therefore harbors about 3000 FSHD patients. With research progress and the development of targeted therapies, patients’ identification through regi...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-018-0960-x |
id |
doaj-1d253328860746cc93b723944ebbca3c |
---|---|
record_format |
Article |
spelling |
doaj-1d253328860746cc93b723944ebbca3c2020-11-25T01:25:06ZengBMCOrphanet Journal of Rare Diseases1750-11722018-12-0113111010.1186/s13023-018-0960-xThe French National Registry of patients with Facioscapulohumeral muscular dystrophyCéline Guien0Gaëlle Blandin1Pauline Lahaut2Benoît Sanson3Katia Nehal4Sitraka Rabarimeriarijaona5Rafaëlle Bernard6Nicolas Lévy7Sabrina Sacconi8Christophe Béroud9Aix Marseille Univ, INSERM, MMG, Bioinformatics & GeneticsAix Marseille Univ, INSERM, MMG, Bioinformatics & GeneticsUniversité Côte d’Azur, Service Système Nerveux Périphérique, Muscle et SLA, Centre Hospitalier Universitaire de NiceUniversité Côte d’Azur, Service Système Nerveux Périphérique, Muscle et SLA, Centre Hospitalier Universitaire de NiceAPHM, Hôpital Timone Enfants, Laboratoire de Génétique MoléculaireAPHM, Hôpital Timone Enfants, Laboratoire de Génétique MoléculaireAPHM, Hôpital Timone Enfants, Laboratoire de Génétique MoléculaireAix Marseille Univ, INSERM, MMG, Bioinformatics & GeneticsUniversité Côte d’Azur, Service Système Nerveux Périphérique, Muscle et SLA, Centre Hospitalier Universitaire de NiceAix Marseille Univ, INSERM, MMG, Bioinformatics & GeneticsAbstract Background Facioscapulohumeral muscular dystrophy is a rare inherited neuromuscular disease with an estimated prevalence of 1/20,000 and France therefore harbors about 3000 FSHD patients. With research progress and the development of targeted therapies, patients’ identification through registries can facilitate and improve recruitment in clinical trials and studies. Results The French National Registry of FSHD patients was designed as a mixed model registry involving both patients and physicians, through self-report and clinical evaluation questionnaires respectively, to collect molecular and clinical data. Because of the limited number of patients, data quality is a major goal of the registry and various automatic data control features have been implemented in the bioinformatics system. In parallel, data are manually validated by molecular and clinical curators. Since its creation in 2013, data from 638 FSHD patients have been collected, representing about 21% of the French FSHD population. The mixed model strategy allowed to collect 59.1% of data from both patients and clinicians; 26 and 14.9% from respectively patients and clinicians only. With the identification of the FSHD1 and FSHD2 forms, specific questionnaires have been designed. Though FSHD2 patients are progressively included, FSHD1 patients still account for the majority (94.9%). The registry is compatible with the FAIR principles as data are Findable, Accessible and Interoperable. We thus used molecular standards and standardized clinical terms used by the FILNEMUS French network of reference centers for the diagnosis and follow-up of patients suffering from a rare neuromuscular disease. The implemented clinical terms mostly map to dictionaries and terminology systems such as SNOMED-CT (75% of terms), CTV3 (61.7%) and NCIt (53.3%). Because of the sensitive nature of data, they are not directly reusable and can only be accessed as aggregated data after evaluation and approval by the registry oversight committee. Conclusions The French National Registry of FSHD patients belongs to a national effort to develop databases, which should now interact with other initiatives to build a European and/or an international FSHD virtual registry for the benefits of patients. It is accessible at www.fshd.fr and various useful information, links, and documents, including a video, are available for patients and professionals.http://link.springer.com/article/10.1186/s13023-018-0960-xPatient registryDatabaseFacioscapulohumeral muscular dystrophyFSHDFSHD1FSHD2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Céline Guien Gaëlle Blandin Pauline Lahaut Benoît Sanson Katia Nehal Sitraka Rabarimeriarijaona Rafaëlle Bernard Nicolas Lévy Sabrina Sacconi Christophe Béroud |
spellingShingle |
Céline Guien Gaëlle Blandin Pauline Lahaut Benoît Sanson Katia Nehal Sitraka Rabarimeriarijaona Rafaëlle Bernard Nicolas Lévy Sabrina Sacconi Christophe Béroud The French National Registry of patients with Facioscapulohumeral muscular dystrophy Orphanet Journal of Rare Diseases Patient registry Database Facioscapulohumeral muscular dystrophy FSHD FSHD1 FSHD2 |
author_facet |
Céline Guien Gaëlle Blandin Pauline Lahaut Benoît Sanson Katia Nehal Sitraka Rabarimeriarijaona Rafaëlle Bernard Nicolas Lévy Sabrina Sacconi Christophe Béroud |
author_sort |
Céline Guien |
title |
The French National Registry of patients with Facioscapulohumeral muscular dystrophy |
title_short |
The French National Registry of patients with Facioscapulohumeral muscular dystrophy |
title_full |
The French National Registry of patients with Facioscapulohumeral muscular dystrophy |
title_fullStr |
The French National Registry of patients with Facioscapulohumeral muscular dystrophy |
title_full_unstemmed |
The French National Registry of patients with Facioscapulohumeral muscular dystrophy |
title_sort |
french national registry of patients with facioscapulohumeral muscular dystrophy |
publisher |
BMC |
series |
Orphanet Journal of Rare Diseases |
issn |
1750-1172 |
publishDate |
2018-12-01 |
description |
Abstract Background Facioscapulohumeral muscular dystrophy is a rare inherited neuromuscular disease with an estimated prevalence of 1/20,000 and France therefore harbors about 3000 FSHD patients. With research progress and the development of targeted therapies, patients’ identification through registries can facilitate and improve recruitment in clinical trials and studies. Results The French National Registry of FSHD patients was designed as a mixed model registry involving both patients and physicians, through self-report and clinical evaluation questionnaires respectively, to collect molecular and clinical data. Because of the limited number of patients, data quality is a major goal of the registry and various automatic data control features have been implemented in the bioinformatics system. In parallel, data are manually validated by molecular and clinical curators. Since its creation in 2013, data from 638 FSHD patients have been collected, representing about 21% of the French FSHD population. The mixed model strategy allowed to collect 59.1% of data from both patients and clinicians; 26 and 14.9% from respectively patients and clinicians only. With the identification of the FSHD1 and FSHD2 forms, specific questionnaires have been designed. Though FSHD2 patients are progressively included, FSHD1 patients still account for the majority (94.9%). The registry is compatible with the FAIR principles as data are Findable, Accessible and Interoperable. We thus used molecular standards and standardized clinical terms used by the FILNEMUS French network of reference centers for the diagnosis and follow-up of patients suffering from a rare neuromuscular disease. The implemented clinical terms mostly map to dictionaries and terminology systems such as SNOMED-CT (75% of terms), CTV3 (61.7%) and NCIt (53.3%). Because of the sensitive nature of data, they are not directly reusable and can only be accessed as aggregated data after evaluation and approval by the registry oversight committee. Conclusions The French National Registry of FSHD patients belongs to a national effort to develop databases, which should now interact with other initiatives to build a European and/or an international FSHD virtual registry for the benefits of patients. It is accessible at www.fshd.fr and various useful information, links, and documents, including a video, are available for patients and professionals. |
topic |
Patient registry Database Facioscapulohumeral muscular dystrophy FSHD FSHD1 FSHD2 |
url |
http://link.springer.com/article/10.1186/s13023-018-0960-x |
work_keys_str_mv |
AT celineguien thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT gaelleblandin thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT paulinelahaut thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT benoitsanson thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT katianehal thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT sitrakarabarimeriarijaona thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT rafaellebernard thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT nicolaslevy thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT sabrinasacconi thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT christopheberoud thefrenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT celineguien frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT gaelleblandin frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT paulinelahaut frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT benoitsanson frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT katianehal frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT sitrakarabarimeriarijaona frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT rafaellebernard frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT nicolaslevy frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT sabrinasacconi frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy AT christopheberoud frenchnationalregistryofpatientswithfacioscapulohumeralmusculardystrophy |
_version_ |
1725115273431744512 |